Prevention of intrathecal drug delivery catheter-related complications

被引:50
作者
Follett, KA
Burchiel, K
Deer, T
DuPen, S
Prager, J
Turner, MS
Coffey, RJ
机构
[1] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[3] Ctr Pain Relief, Charleston, WV USA
[4] Swedish Hosp Pain Management, Seattle, WA USA
[5] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[6] Indianapolis Neurosurg Grp, Indianapolis, IN USA
[7] Medtronic Inc, Minneapolis, MN USA
来源
NEUROMODULATION | 2003年 / 6卷 / 01期
关键词
drug administration system; intrathecal catheter; intrathecal drug delivery; pain; pump; spasticity;
D O I
10.1046/j.1525-1403.2003.03005.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In an effort to improve the performance of implantable intrathecal drug delivery systems, a group of physicians experienced in the management of such devices reviewed surgical practices and principles that were associated with low catheter-related complication rates. Clinical study and postmarket data identified physicians whose patients experienced a relatively low rate of catheter-related complications. Six of those physicians (three anesthesiologists and three neurosurgeons) reviewed the number and types of intrathecal drug pumps and catheters they had implanted, with an emphasis on the specific details of successful catheter implantation techniques. The authors pooled their experiences to reach a consensus on implant techniques that are associated with a low rate of postoperative complications. The authors found that complications were minimized by the use of specific methods for catheter placement that included: a mid-to-upper lumbar dural entry level, a shallow-angle paramedian oblique insertion trajectory, and meticulous catheter anchoring and tunneling techniques. Systemic antibiotic prophylaxis, attention to pump pocket location, and surgical wound closure techniques also were important in reducing the incidence of postoperative device-related complications. Their experience indicates that specific implantation techniques using a variety of catheters and accessories can be expected to reduce the incidence of complications after implantation of intrathecal drug administration systems.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 12 条
[1]   INTRATHECAL BACLOFEN FOR INTRACTABLE SPASTICITY OF SPINAL ORIGIN - RESULTS OF A LONG-TERM MULTICENTER STUDY [J].
COFFEY, RJ ;
CAHILL, D ;
STEERS, W ;
PARK, TS ;
ORDIA, J ;
MEYTHALER, J ;
HERMAN, R ;
SHETTER, AG ;
LEVY, R ;
GILL, B ;
SMITH, R ;
WILBERGER, J ;
LOESER, JD ;
CHABAL, C ;
FELER, C ;
ROBERTSON, JT ;
PENN, RD ;
CLARKE, A ;
BURCHIEL, KJ ;
LEIBROCK, LG .
JOURNAL OF NEUROSURGERY, 1993, 78 (02) :226-232
[2]  
COOMBS DW, 1981, LANCET, V2, P425
[3]   A prospective study of catheter-related complications of intrathecal drug delivery systems [J].
Follett, KA ;
Naumann, CP .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (03) :209-215
[4]  
HAINES SJ, 1994, NEUROSURGERY, V34, P87
[5]  
Haughton VM, 1999, SPINAL DRUG DELIVERY, P531
[6]  
KESTLE JRW, 1993, CHILD NERV SYST, V9, P163
[7]   Reliability and clinical utility of an implanted intraspinal catheter used in the treatment of spasticity and pain [J].
Krames, ES ;
Chapple, I .
NEUROMODULATION, 2000, 3 (01) :7-14
[8]   Cerebrospinal fluid shunt infection: a prospective study of risk factors [J].
Kulkarni, AV ;
Drake, JM ;
Lamberti-Pasculli, M .
JOURNAL OF NEUROSURGERY, 2001, 94 (02) :195-201
[9]   EFFICACY OF ANTIMICROBIAL PROPHYLAXIS IN PLACEMENT OF CEREBROSPINAL-FLUID SHUNTS - METAANALYSIS [J].
LANGLEY, JM ;
LEBLANC, JC ;
DRAKE, J ;
MILNER, R .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) :98-103
[10]   Drug adverse events and system complications of intrathecal opioid delivery for pain: Origins, detection, manifestations, and management [J].
Naumann, C ;
Erdine, S ;
Koulousakis, A ;
Van Buyten, JP ;
Schuchard, M .
NEUROMODULATION, 1999, 2 (02) :92-107